INDICATION
DOVATO is indicated as a complete regimen to treat HIV-1 infection in adults with no antiretroviral (ARV) treatment history or to replace the current ARV regimen in those who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable ARV regimen with no history of treatment failure and no known resistance to any component of DOVATO.

DISCOVER DOVATO

TANGO Trial

TANGO Trial

See 144-week trial results for a switch to DOVATO in appropriate virologically suppressed adults

LEARN MORE
GEMINI 1 & 2 Trials

GEMINI 1 & 2 Trials

See trial results and 144-week long-term data

SEE LONG-TERM DATA
STAT icon

Rapid Initiation Trial

See trial results using DOVATO in a rapid initiation study

LEARN MORE
#1 fastest growing callout desktop
#1 callout mobile

Hear From Your Peers on
How They're Treating HIV Today

Hear From Your Peers on
How They're Treating HIV Today

Calendar Icon

Sign up for our
next webinar

A DEEPER LOOK AT DOVATO

Request a Rep

Request a Rep

Request a visit from a ViiV Healthcare representative in your area

REQUEST NOW
Email Updates

Email Updates

Sign up to get the latest updates on DOVATO

SIGN UP NOW
Pill Icon

ViiV Medical Information

View our medical information library if you have a question about DOVATO

LEARN MORE

Connect With Us

Schedule icon

Medical Meeting

If you have a question for our medical experts, choose a time that works for you.

SCHEDULE A MEETING
Chat Icon

Medical Chat

If you have a question, medical experts are available Monday through Friday 9am-6pm ET.

CHAT NOW
Phone Icon

Call Us

1-877-844-8872
Monday-Friday, 8:30am-5:30pm ET.

CALL NOW

References:

  1. The INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795-807. doi:10.1056/NEJMoa1506816
  2. Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between1 1996 and 2013: a collaborative analysis of cohort studies. Lancet. 2017;4(8):e349-e356. doi:10.1016/S2352-3018(17)30066-8
  3. Data on file, ViiV Healthcare.

DLLWCNT220008